Biotin-Targeted Au(I) Radiosensitizer for Cancer Synergistic Therapy by Intervening with Redox Homeostasis and Inducing Ferroptosis-Reference-Cited by-同舟云学术

Biotin-Targeted Au(I) Radiosensitizer for Cancer Synergistic Therapy by Intervening with Redox Homeostasis and Inducing Ferroptosis

Published:2022-06-10 Issue:12 Volume:65 Page:8401-8415
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Yang Zhibin¹²,Huang Sheng¹,Liu Yu¹,Chang Xingyu¹,Liang Yanshan¹,Li Xi³,Xu Zhongren¹,Wang Shiyu³,Lu Yunlong¹,Liu Yuan³,Liu Wukun¹⁴^ORCID

Affiliation:

1. Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, School of Medicine & Holistic Integrative Medicine, Nanjing University of Chinese Medicine, Nanjing 210023, P. R. China

2. Yunnan Provincial Key Laboratory of Entomological Biopharmaceutical R&D, Dali University, Dali 671000, P. R. China

3. Department of Gynecology and Obstetrics, Shanghai General Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200025, P. R. China

4. State Key Laboratory of Coordination Chemistry, Nanjing University, Nanjing 210023, P. R. China

Funder

Nanjing University of Chinese Medicine

National Natural Science Foundation of China

Priority Academic Program Development of Jiangsu Higher Education Institutions

Jiangsu Province Graduate Practice Innovation Program

?Innovative and Entrepreneurial Team? Program of Jiangsu Province

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.2c00300

Reference41 articles.

1. Concomitant chemoradiotherapy versus acceleration of radiotherapy with or without concomitant chemotherapy in locally advanced head and neck carcinoma (GORTEC 99-02): an open-label phase 3 randomised trial

2. NCCN Guidelines Insights: Cervical Cancer, Version 1.2020

3. Risk assessment model for overall survival in patients with locally advanced cervical cancer treated with definitive concurrent chemoradiotherapy

4. Analysis of the Cost Effectiveness of Concurrent Cisplatin-Based Chemoradiation in Cervical Cancer: Implications from Five Randomized Trials

5. The status of platinum anticancer drugs in the clinic and in clinical trials

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeted delivery of nano-radiosensitizers for tumor radiotherapy;Coordination Chemistry Reviews;2024-11

2. Bio-interactions, biomimetic activity and anticancer investigation of Cu(II) and Co(II) “end-off” homo-dinuclear complexes;Journal of Molecular Liquids;2024-09

3. Synthesis and antitumor activity of gold(I) N-heterocyclic carbene with dithiocarbamate and alkynyl complexes;Inorganica Chimica Acta;2024-08

4. Antioxidant Enzymes and Their Potential Use in Breast Cancer Treatment;International Journal of Molecular Sciences;2024-05-23

5. Ferroptosis: Frenemy of Radiotherapy;International Journal of Molecular Sciences;2024-03-25